Similar articles

• Analysing the efficacy of clozapine.

  Kho KH. Kho KH. Br J Psychiatry. 2004 Jun;184:539-40; author reply 540. doi: 10.1192/bjp.184.6.539-a. Br J Psychiatry. 2004. PMID: 15211714 No abstract available.
• Clozapine for Treatment-Resistant Schizophrenia: Still the Gold Standard?

  Taylor DM. Taylor DM. CNS Drugs. 2017 Mar;31(3):177-180. doi: 10.1007/s40263-017-0411-6. CNS Drugs. 2017. PMID: 28258419 No abstract available.
• Analysing the efficacy of clozapine.

  Ahmer S. Ahmer S. Br J Psychiatry. 2004 Sep;185:264. doi: 10.1192/bjp.185.3.264. Br J Psychiatry. 2004. PMID: 15339837 No abstract available.
• Clozapine augmented with glutamate modulators in refractory schizophrenia: a review and metaanalysis.

  Veerman SR, Schulte PF, Begemann MJ, Engelsbel F, de Haan L. Veerman SR, et al. Pharmacopsychiatry. 2014 Sep;47(6):185-94. doi: 10.1055/s-0034-1383656. Epub 2014 Jul 7. Pharmacopsychiatry. 2014. PMID: 25002291 Review.
• Non-glutamatergic clozapine augmentation strategies: a review and meta-analysis.

  Veerman SR, Schulte PF, Begemann MJ, de Haan L. Veerman SR, et al. Pharmacopsychiatry. 2014 Nov;47(7):231-8. doi: 10.1055/s-0034-1385930. Epub 2014 Aug 14. Pharmacopsychiatry. 2014. PMID: 25121994 Review.